by SoCal TBA
讓來自南加的 Bio 咖們,七嘴八舌地為你帶來台美生技人關心的時事要聞! 本節目由南加州台灣生技協會 SoCal Taiwanese Biotechnology Association (SoCal TBA) 製作。 Email: [email protected] | Instagram: https://www.instagram.com/socaltba/ | Facebook: https://www.facebook.com/SoCalTBA/ | LinkedIn: https://www.linkedin.com/company/socaltba
Language
🇨🇳
Publishing Since
3/7/2022
Email Addresses
1 available
Phone Numbers
0 available
October 2, 2024
<p>人類可以用意識控制機器了?!今天讓我們一起來了解神經生技新創Neuralink研發的腦機介面最新進展吧!</p>
August 15, 2024
<p>今天要跟大家介紹什麼是個人化癌症疫苗及其最新進展 讓我們一起來了解如何利用mRNA疫苗對抗癌症吧!</p>
July 29, 2024
<p>今天要跟大家介紹一項阿茲海默症最新的研究 就讓我們一起來了解APOE4基因是如何影響阿茲海默罹病機率 以及我們可以如何應對吧~</p>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.